X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3335) 3335
Publication (251) 251
Newsletter (36) 36
Book Review (13) 13
Newspaper Article (8) 8
Book Chapter (5) 5
Magazine Article (5) 5
Conference Proceeding (2) 2
Book / eBook (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2988) 2988
interferon alpha-2 (2360) 2360
recombinant proteins (2280) 2280
male (1832) 1832
female (1704) 1704
interferon-alpha - therapeutic use (1671) 1671
middle aged (1526) 1526
adult (1428) 1428
aged (857) 857
interferon-alpha - administration & dosage (767) 767
interferon (719) 719
antiviral agents - therapeutic use (700) 700
interferon-alpha - adverse effects (685) 685
hepatitis c, chronic - drug therapy (597) 597
treatment outcome (577) 577
gastroenterology & hepatology (557) 557
drug therapy, combination (509) 509
therapy (468) 468
oncology (447) 447
ribavirin - therapeutic use (435) 435
index medicus (414) 414
hepacivirus - genetics (380) 380
hepatitis c (326) 326
polyethylene glycols - therapeutic use (319) 319
genotype (314) 314
ribavirin (293) 293
antineoplastic combined chemotherapy protocols - therapeutic use (278) 278
follow-up studies (257) 257
drug administration schedule (252) 252
animals (247) 247
time factors (245) 245
antiviral agents - adverse effects (242) 242
adolescent (239) 239
interferon-alpha - pharmacology (239) 239
interferon type i - therapeutic use (231) 231
antiviral agents - administration & dosage (230) 230
immunology (227) 227
recombinant proteins - therapeutic use (225) 225
hepatitis c virus (223) 223
hepatitis c - therapy (219) 219
chronic disease (214) 214
interferon-alpha (213) 213
infection (211) 211
hepatitis c - drug therapy (210) 210
rna, viral - blood (209) 209
medicine, general & internal (204) 204
interferon alpha (201) 201
prospective studies (201) 201
hematology (200) 200
combined modality therapy (196) 196
virus-infection (189) 189
dose-response relationship, drug (187) 187
interleukins - genetics (185) 185
ribavirin - administration & dosage (182) 182
biological response modifiers (177) 177
antineoplastic agents - therapeutic use (174) 174
health aspects (174) 174
alanine transaminase - blood (168) 168
alpha (168) 168
alpha-interferon (166) 166
hepatitis c, chronic - virology (166) 166
remission induction (160) 160
viral load (156) 156
recurrence (146) 146
chronic hepatitis c (144) 144
pharmacology & pharmacy (143) 143
care and treatment (137) 137
combination (135) 135
ribavirin - adverse effects (134) 134
plus ribavirin (133) 133
expression (132) 132
infectious diseases (130) 130
cancer (129) 129
mice (129) 129
prognosis (129) 129
drug therapy (127) 127
hepacivirus - drug effects (124) 124
virus (124) 124
polyethylene glycols - administration & dosage (122) 122
virology (122) 122
hepatitis c, chronic - genetics (120) 120
hepatitis (119) 119
retrospective studies (119) 119
aged, 80 and over (118) 118
research article (118) 118
trial (118) 118
hepatitis c, chronic - complications (117) 117
controlled trial (116) 116
hepacivirus - isolation & purification (115) 115
immunotherapy (114) 114
liver - pathology (112) 112
injections, subcutaneous (109) 109
chemotherapy (108) 108
cells (107) 107
polymerase chain reaction (104) 104
molecular sequence data (103) 103
polyethylene glycols - adverse effects (103) 103
risk factors (103) 103
pilot projects (102) 102
biochemistry & molecular biology (100) 100
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3211) 3211
French (61) 61
Spanish (29) 29
Russian (24) 24
Japanese (22) 22
German (18) 18
Portuguese (9) 9
Italian (5) 5
Ukrainian (4) 4
Korean (3) 3
Serbian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLOS ONE, ISSN 1932-6203, 06/2016, Volume 11, Issue 6
The ultimate goal of pegylated interferon-alfa-2a (Peg-IFN-alpha) therapy in chronic hepatitis B (CHB) infection is HBsAg seroconversion. Even though B cells... 
PLASMACYTOID DENDRITIC CELLS | INTERFERON-ALPHA | SOLUBLE CD30 | VIRUS-INFECTION | PEGINTERFERON ALPHA-2A | MULTIDISCIPLINARY SCIENCES | PERIPHERAL-BLOOD | DIFFERENTIATION | COMPARTMENT | MEMORY B | LYMPHOCYTES
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 4, p. e10228
Journal Article
Journal Article
BMC Pharmacology, ISSN 1471-2210, 11/2010, Volume 10, Issue 1, pp. 15 - 15
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 2010, Volume 138, Issue 4, pp. 1338 - 1345.e7
Journal Article
Nature, ISSN 0028-0836, 09/2009, Volume 461, Issue 7262, pp. 399 - 401
Journal Article
Hepatology, ISSN 0270-9139, 09/2010, Volume 52, Issue 3, pp. 833 - 844
Journal Article